We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Argent Biopharma Limited | LSE:RGT | London | Ordinary Share | AU0000326647 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 6.50 | 5.00 | 8.00 | 6.50 | 6.50 | 6.50 | 1,175 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:3835T
ReGen Therapeutics PLC
17 December 2003
ReGen Therapeutics Plc
17 December 2003
DECLARATION OF SHAREHOLDING
ReGen Therapeutics Plc (the "Company") announces that it was notified on 17
December 2003 that, pursuant to a placing, City Equities Limited acquired
10,000,000 ordinary shares of the Company on 16 December 2003 representing 3.89%
of the issued share capital of the Company. On the same date, City Equities
Limited sold 10,000,000 ordinary shares to certain of its private customers and
no longer has a notifiable interest in the Company
For further information, please contact:
Andrew Marshall
Tel. 020 7960 6007
Marshall Robinson Roe
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEASAXFEPDFFE
1 Year Argent Biopharma Chart |
1 Month Argent Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
